|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
The Power of Public Relations
PMs find new ground for reinforcing marketing messages and targeting the media mix.
Advertisement
Articles in this issue
almost 25 years ago
Market Research 101almost 25 years ago
World-Class Marketing Plansalmost 25 years ago
How to Win Friends and Influence R&Dalmost 25 years ago
Working with an Agencyalmost 25 years ago
A Strategic Overviewalmost 25 years ago
The Regulatory EnvironmentNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5